tiprankstipranks
Advertisement
Advertisement

Jubilant Ingrevia Posts Stable Q3 FY26 Margins on Volume Growth, Declares Interim Dividend

Story Highlights
  • Jubilant Ingrevia delivered stable Q3 FY26 margins with softer prices offset by strong volume growth.
  • Nine-month FY26 results show rising revenue, EBITDA and PAT, prompting a 250% interim dividend.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Jubilant Ingrevia Posts Stable Q3 FY26 Margins on Volume Growth, Declares Interim Dividend

Claim 55% Off TipRanks

Jubilant Ingrevia Ltd. ( (IN:JUBLINGREA) ) has provided an announcement.

Jubilant Ingrevia’s board has approved the financial results for the quarter ended 31 December 2025, reporting stable overall performance despite soft pricing across all three business segments. For Q3 FY26, total revenue stood at ₹1,051 crore, down 1% year-on-year and 6% sequentially, while EBITDA came in at ₹136 crore with margins steady at 13%, and profit after tax declined 32% year-on-year to ₹47 crore due to exceptional items. Over the first nine months of FY26, the company delivered double-digit volume growth, leading to a 3% rise in revenue to ₹3,210 crore, an 8% increase in EBITDA to ₹436 crore and an 8% rise in post-exceptional PAT to ₹191 crore, underlining resilience amid industry-wide pricing pressure and elevated energy costs. Management highlighted continued growth momentum in Speciality Chemicals, healthy volume growth in Nutrition and sustained market share with volume gains in Chemical Intermediates, while noting steady demand in pharmaceutical markets and a gradual volume recovery in agrochemicals despite ongoing demand–supply imbalances. Reflecting confidence in its financial position, the board has recommended an interim dividend of 250%, or ₹2.5 per equity share, offering a tangible payout to shareholders even as the company pursues cost initiatives to mitigate short-term margin pressures and position for improving market conditions.

More about Jubilant Ingrevia Ltd.

Jubilant Ingrevia Limited operates in the chemicals industry with a portfolio spanning Speciality Chemicals, Nutrition products and Chemical Intermediates, serving pharmaceutical, agrochemical and other end-use markets in India and globally. The company focuses on value-added fine and specialty chemicals, pyridine-based products and acetyls, and positions itself as an integrated supplier across key industrial and life-science sectors.

Average Trading Volume: 13,022

Technical Sentiment Signal: Sell

Current Market Cap: 104.2B INR

For an in-depth examination of JUBLINGREA stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1